GGrantIndex
← Search

CORE--FLOW CYTOMETRY FACILITY

$78,870P30FY2002CANIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications, trials & patents

Trial NCT05340673Trial NCT05198830Trial NCT02590107Trial NCT02535325Trial NCT02451124Trial NCT02419846Trial NCT02417948Trial NCT02392377Trial NCT02388932Trial NCT02383433Trial NCT02375477Trial NCT02354326Trial NCT02345460Trial NCT02342730Trial NCT02337465Trial NCT02327390Trial NCT02319889Trial NCT02307474Trial NCT02287636Trial NCT02252393Trial NCT02181478Trial NCT02179762Trial NCT02163317Trial NCT02158767Trial NCT02153450Trial NCT02135562Trial NCT02131207Trial NCT02129582Trial NCT02129569Trial NCT02129517Trial NCT02129218Trial NCT02128373Trial NCT02108587Trial NCT02100423Trial NCT02084147Trial NCT02082405Trial NCT02081794Trial NCT02079155Trial NCT02073097Trial NCT02073045Trial NCT02071901Trial NCT02070458Trial NCT02070419Trial NCT02055586Trial NCT02037048Trial NCT01973062Trial NCT01959490Trial NCT01959477Trial NCT01954784Trial NCT01954732Trial NCT01951885Trial NCT01939028Trial NCT01928485Trial NCT01894061Trial NCT01408043Trial NCT00991991Trial NCT00970684Trial NCT00961220Trial NCT00956475Trial NCT00952939Trial NCT00949247Trial NCT00945061Trial NCT00941720Trial NCT00941070Trial NCT00939510Trial NCT00918892Trial NCT00918788Trial NCT00918658Trial NCT00918216Trial NCT00910039Trial NCT00909662Trial NCT00908739Trial NCT00908141Trial NCT00907699Trial NCT00905086Trial NCT00900133Trial NCT00899158Trial NCT00899132Trial NCT00898573Trial NCT00898274Trial NCT00897143Trial NCT00892385Trial NCT00873600Trial NCT00873002Trial NCT00866320Trial NCT00856115Trial NCT00853021Trial NCT00842452Trial NCT00809185Trial NCT00796978Trial NCT00795678Trial NCT00769951Trial NCT00769249Trial NCT00752323Trial NCT00740961Trial NCT00736216Trial NCT00735514Trial NCT00733252Trial NCT00732745Trial NCT00732173

Abstract

DESCRIPTION (provided by applicant): The CWRU Cancer Center Flow Cytometry resource is an established core that has a history of stable direction (Director: 15 years), management (6 & 7 years), NCI funding (13 years), and supporting cancer research with up-to-date, well-maintained flow cytometry and cell sorting instrumentation. The director, James Jacobberger, has a major interest in the science of Cytometry. Considered to be one of the field?s leaders, Dr. Jacobberger has a strong commitment to developing and maintaining a robust and sophisticated Flow Cytometry Core that is especially flexible and can respond to the diverse needs of the CWRU Cancer Center investigators. The manager, Mr. Sramkoski, is a trained Medical Technician, with specialization in Cytometry who is equally committed. Together they have 37 years experience in the field and provide a superior level of expertise and guidance during experimental design and protocol development. Use of the core has grown steadily for 15 years with an especially sharp increase in recent years. In any one year there are approximately 70 principal investigators (users) drawn from a base of approximately 127 active investigators who have used the facility within the first few years. (Since inception, the core has assisted 167 investigators.) The facility currently operates at full capacity with two instruments - a single laser 4 color analyzer and a 4 laser, 4 color, 6 parameter cell sorter. An order has been placed for a new Becton-Dickinson LSR analyzer with 3 lasers and 6 color capability. A grant has been submitted for an additional (high speed) cell sorter that will have 5 lasers and 8 color capacity. Acquisition of these instruments will ensure that the facility can continue to support growth of cancer research at CWRU. Since the last competitive renewal an Assistant Manager has been hired to handle the increased work load and to establish a staining service. The facility operates with planned development that does and will provide outstanding technology and science in Cytometry for the Cancer Center?s membership.

View original record on NIH RePORTER →